ObsEva SA NASDAQ:OBSV is reporting this earnings, what to expect.
ObsEva SA NASDAQ:OBSV headquartered in Switzerland is reporting their earnings on 05/16/2018 before the bell. Street forecast for the quarter ending March 2018 is $-0.46.
According to stock market daily analyst this is Lower then same time previous year. ObsEva SA, reported EPS for the same quarter last year was $-0.58.
Overview of ObsEva SA NASDAQ:OBSV
Founded in Switzerland in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.
ObsEva is led by a strong management team with substantial experience in successfully developing and commercializing pharmaceutical products in our target market. ObsEva’s team members include trained obstetricians and gynecologists with an in-depth understanding of patient and physician needs. Our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.
|% Change from 52 Week Low|
|% Change from 52 Week High|